Viewing Study NCT06519318



Ignite Creation Date: 2024-10-26 @ 3:35 PM
Last Modification Date: 2024-10-26 @ 3:35 PM
Study NCT ID: NCT06519318
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-07-19

Brief Title: Validity And Reliability of The Incremental Shuttle Walk Test In Type 2 Diabetes Mellitus
Sponsor: None
Organization: None

Study Overview

Official Title: Validity And Reliability of The Incremental Shuttle Walk Test In Individuals With Type 2 Diabetes Mellitus
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The aim of our study was to determine the validity and reliability of the incremental shuttle walk test ISWT in patients with type 2 diabetes mellitusThis study involves the evaluation of the validity and test-retest reliability of the ISWT

The assessments will be performed in two separate time periods At the first visit baseline assessments of the patient will be performed These assessments include the recording of demographic information and the ISWT and 6 minute walk test assessments Both tests will be performed with a 30-minute interval between them

A retest will be performed 1 week after the initial assessment
Detailed Description: Diabetes mellitus is a hormonal metabolic and chronic disease characterised by hyperglycaemia resulting from a partial or complete deficiency of the hormone insulin or a defect in insulin-sensing receptors Functional capacity is a vital marker for many chronic diseases including Type 2 diabetes Many things about the mechanism of decreased functional capacity specific to individuals with type 2 diabetes have not yet been clarified As a result of the researches it has been concluded that the deterioration in functional capacity is mostly related to glycaemic control and complications

The Incremental Shuttle Walk Test ISWT is a maximal test that is widely used for the assessment of functional capacity and exercise tolerance because it is low cost and easy to perform The incremental speed shuttle walk test was first described in 1992 to assess exercise capacity in patients with COPD Compared to other field tests ISWT is recommended because it shows high levels of maximum oxygen uptake peak VO2 and provides physiological results closest to cardiopulmonary exercise testing CPET which is considered as the gold standard in the assessment of functional capacity

The aim of our study was to determine the validity and reliability of the increasing speed shuttle walking test in patients with type 2 diabetes mellitus

This study involves the evaluation of the validity and test-retest reliability of the ISWT

The assessments will be performed in two separate time periods At the first visit baseline assessments of the patient will be performed These assessments include the recording of demographic information and the ISWT and 6 minute walk test assessments Both tests will be performed with a 30-minute interval between them

A retest will be performed 1 week after the initial assessment

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None